EUVIMEDEUVIMED entdecken
Crossref

What can we learn from cannabinoid trials?

Kaisu H Pitkälä iD, Hanna-Maria Roitto iD

Age and Ageing · 04.09.2026 · 55 (9)

DOI: 10.1093/ageing/afag294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 29.09.2026. Verfasst von Kaisu H Pitkälä und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, University of Helsinki, PO BOX 20, 00014 Helsinki, Finland and Helsinki University Hospital, Unit of Primary Health Care, Helsinki, …. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

agitationbehavioural disordercannabinoidsdementiaolder people

Autor:innen und Institutionen

  • Medical Faculty, University of Helsinki, PO BOX 20, 00014 Helsinki, Finland and Helsinki University Hospital, Unit of Primary Health Care, Helsinki, Finland.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Geriatrics, Wellbeing County of Pirkanmaa, Tampere University Hospital, Tampere, Finland.

ORCID-Profile: Kaisu H Pitkälä, Hanna-Maria Roitto

Zitieren

APA

Pitkälä, K. H., & Roitto, H. M. (2026). What can we learn from cannabinoid trials?. Age and Ageing, 55(9). https://doi.org/10.1093/ageing/afag294

Vancouver

Pitkälä KH, Roitto HM. What can we learn from cannabinoid trials?. Age and Ageing. 2026;55(9). doi:10.1093/ageing/afag294

BibTeX
@article{Pitkl2026,
  author = {Pitkälä, Kaisu H and Roitto, Hanna-Maria},
  title = {What can we learn from cannabinoid trials?},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {9},
  doi = {10.1093/ageing/afag294}
}
Kostenlos starten →